The downregulation of KCC2 can lead to increased neuronal excitability associated with numerous psychiatric and neurologic disorders including epilepsy (Kahle et al., 2016; Chen et al., 2017; Duy et al., 2019; Goutierre et al., 2019). The gene discussed is SLC12A5; the disease is nervous system disorder.